Document is current
Any future updates will be listed below
-
Authors
Glorieux, Francis H. https://orcid.org/0000-0001-6616-3484
Bonewald, Lynda F.
Harvey, Nicholas C.
van der Meulen, Marjolein C. H.
-
Funding
Funding for this research was provided by:
Kyowa Hakko Kirin
- License Information
-
More Information
Article History
Received: 29 October 2021
Accepted: 19 December 2021
First Online: 31 January 2022
Declarations
:
: Not applicable.
: All authors have read and approved the final manuscript.
: LFB reports no competing interests. FHG reports consultancy fees from Amgen, Novartis, Kyowa Kirin, Ultragenyx, and Mereo BioPharma. NCH reports consultancy, lecture fees, and honoraria from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health, and Internis Pharmaceuticals. MvdM reports no competing interests.
